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ABSTRACT 
Objective 
Develop and internally validate risk models and a clinical risk score tool to predict incident 
radiographic knee osteoarthritis (RKOA) in middle-aged women. 
Methods 
We analysed 649 women in the Chingford 1000 Women study. The outcome was incident 
RKOA, defined as Kellgren/Lawrence grade 0-1 at baseline and ≥2 at year 5. We estimated 
predictors’ effects on the outcome using logistic regression models. Two models were 
generated. The clinical model considered patient characteristics, medication, biomarkers, and 
knee symptoms. The radiographic model considered the same factors, plus radiographic factors 
(e.g., angle between the acetabular roof and ilium’s vertical cortex (hip α-angle)). The models 
were internally validated. Model performance was assessed using calibration and 
discrimination (area under the receiver characteristic curve, AUC).  
Results 
The clinical model contained age, quadriceps circumference, and a cartilage degradation 
marker (CTX-II) as predictors (AUC = 0.692). The radiographic model contained older age, 
greater quadriceps circumference, knee pain, knee baseline Kellgren/Lawrence 1 (versus 0), 
greater hip α-angle, greater spinal bone mineral density, and contralateral RKOA at baseline 
as predictors (AUC = 0.797). Calibration tests showed good agreement between the observed 
and predicted incident RKOA. A clinical risk score tool was developed from the clinical model. 
Conclusion 
Two models predicting incident RKOA within 4 years were developed; including radiographic 
variables improved model performance. First-time predictor hip α-angle and contralateral 
RKOA suggest osteoarthritis origins beyond the knee. The clinical tool has the potential to help 
Predicting incident RKOA in women 
 5 
physicians identify patients at risk of RKOA in routine practice, but should be externally 
validated.  
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SIGNIFICANCE AND INNOVATIONS 
• Identifying women with knees at high risk of developing radiographic knee osteoarthritis 
(RKOA) will enable preventive measures to be tested. To do so, we have developed clinical 
and radiological predictive models for short-term incidence of RKOA. 
• We have generated a risk score tool to help clinicians use the clinical model and inform 
their patients about their risk of developing osteoarthritis.  
• Both models and the risk score tool could be useful in identifying participants at risk of 
developing osteoarthritis in the short-term for clinical trials. 
• The radiographic model selected hip α-angle, bone mineral density at the spine lumbar, and 
contralateral knee osteoarthritis as predictors of RKOA, suggesting osteoarthritis origins 
beyond the knee area. 
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Knee osteoarthritis is one of the greatest contributors to global disability and a major global 
public health burden (1). It was the indication for surgery in 96% of the 98,147 primary knee 
joint replacements conducted in the United Kingdom in 2016 (2). The current treatment for 
knee osteoarthritis pain is limited to symptom relief with analgesics and/or physiotherapy. 
Preventing knee osteoarthritis is thus an increased focus of public health. 
 
Previous studies have identified risk factors for the incidence and progression of radiographic 
knee osteoarthritis (RKOA), such as older age, female gender, and higher body mass index 
(BMI) (3-6). However, only three prognostic models have been developed for incident RKOA 
(7-9). Two of these models were developed using 9 and 12 years of participant follow-up data 
(7, 9). The most recent study followed participants for 5 years to identify rapid progression and 
considered radiographic tibiofemoral osteoarthritis as the outcome (8).  
 
As the rate at which knee osteoarthritis progresses varies considerably between patients (10), 
a model for short-term incident RKOA is needed to identify homogeneous phenotypes of 
patients, to facilitate forecasting and target potential treatments (11). Many of the known risk 
factors for RKOA have only been studied in isolation (12, 13). Their combined effects and any 
other risk factors for the onset of short-term RKOA are needed to better identify those at risk.  
 
This is the first study to asses a wide range of potential predictors that includes physical 
assessment, sociodemographic characteristics, medication, biomarkers, medical history 
(family history, knee pain, activity associated with a painful knee, and occupation), spine and 
hip radiographs and densitometries, and lifestyle. Incorporating new predictors in clinical 
prediction models adds value, improving the information available to clinicians and patients 
when deciding on preventive strategies to reduce rapid disease incidence. A description of 
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patients at risk of rapid progression to RKOA will also help in selecting participants for 
randomised controlled trials of new interventions.  
 
We aimed to develop and internally validate a prognostic model for short-term incidence of 
RKOA in a population-based cohort of women, focusing on knee-level risk factors. We also 
aimed to develop a clinical risk prediction tool to help clinicians to identify women who are 
most likely to develop RKOA within 4 years. 
 
MATERIALS AND METHODS 
Data source and sample size 
This study was carried out retrospectively using data from the Chingford 1000 Women study. 
This is a well-described prospective population-based cohort of 1003 women seen annually for 
osteoporosis and osteoarthritis over 23 years (3). Women were selected from the age/sex 
register of a large general practice in Chingford, North London, UK. They lived in a middle-
class area and were mostly white (98%) and middle-aged (44-67 years). For the purpose of this 
analysis, women were recruited at baseline between 1988 and 1989, and seen again 4 years 
later.  
 
Participants 
The unit of analysis was the knee. Each woman participated with one or both knees, which 
were radiographed at baseline (year 1) and follow-up (year 5). Exclusion criteria for 
participants were any indication of inflammatory arthritis (rheumatoid arthritis or lupus) or a 
neurological medical condition (poliomyelitis, Parkinson’s disease, stroke, multiple sclerosis, 
or cerebral palsy) at baseline or year 10, as this information was not available for year 5. Fifty 
participants were excluded using these criteria. Individual knees were also excluded if they had 
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a Kellgren and Lawrence (K/L) grade of 2 or more (14), an osteophyte (lateral or medial), or 
joint space narrowing (JSN) of grade 1 or more at baseline (10).  
 
The ethics committee approved the Chingford study (reference number: LREC R & WF 96), 
and written informed consent was obtained from each participant.  
 
Outcome  
The outcome was incident RKOA, defined as a knee with a K/L grade of 0 or 1 at baseline and 
of grade 2 or more at year 5. The K/L classification progresses from grade 0 to 4, based on X-
rays, where 0 = normal; 1 = no JSN and possible osteophyte; 2 = possible JSN and definite 
osteophyte; 3 = definite JSN and multiple osteophytes, sclerosis, and possible bony deformity; 
and 4 = marked JSN, large osteophytes, severe sclerosis, and definite bony deformity (15, 16). 
The Chingford study collected weight-bearing anteroposterior-view radiographs of the knee 
for all participants at baseline and follow-up. These X-rays were used to assign each knee a 
K/L grade, using previously described protocols (3, 17).  
 
Predictor variables 
The Chingford investigators collected around 700 variables at baseline. A panel of experts in 
osteoarthritis research selected candidate predictors for RKOA from these variables in a three-
round Delphi process. Categorical variables with under five values in at least one category and 
variables with a poor association with the outcome (P-value > 0.2) were excluded. The 
remaining potential predictors were used to develop the model. Supplementary Tables S1-S6 
list the potential predictors and Supplementary Text S1 describes how the predictors were 
assessed. 
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Statistics 
We developed the prediction model as follows (18, 19):  
Step 1: To address the issue of missing data, we generated 50 imputed datasets (20). The 
linearity of continuous variables with incident RKOA was assessed using fractional 
polynomials.  
Step 2: We evaluated the independent associations between the potential predictor variables 
and RKOA incidence with logistic regression, using clustered standard errors at the person-
level. Two hundred bootstrap samples with replacement were combined with the 50 imputed 
datasets. Within each bootstrap sample, automatic backward selection was applied using a 
significance level of 0.157 (21), corresponding to the Akaike information criterion. 
Step 3: Variables that appeared in at least 70% of the bootstrap samples were retained in the 
final models (22). We developed two models. The first only considered variables that clinicians 
routinely have access to: patient characteristics, medications, biomarker risk factors, and knee 
symptoms (clinical model). The second also considered radiographic variables (radiographic 
model).  
 
Internal validation 
We used 200 bootstrap samples with replacement combined with multiple imputations to assess 
bias-corrected estimates of predictive ability.  
 
Further details of the multiple imputation, bootstrapping, and internal validation methods are 
described in Supplementary Text S1.  
 
Model performance 
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We assessed the models’ predictive performance using calibration and discrimination measures 
(21). The area under the receiver characteristic curve (AUC) was used to assess discrimination. 
Calibration – how closely predicted risk corresponds with observed risk – was assessed visually 
using calibration plots.  
 
Clinical scoring tool 
We created a points-based risk-scoring tool from the clinical model for easy clinical use, using 
previously described methods (23, 24). The tool estimates the short-term risk of incident 
RKOA.  
 
All analyses were conducted using Stata version 13.1. We followed the TRIPOD (Transparent 
Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) guideline 
to properly report this study (25). 
 
RESULTS 
Study characteristics  
We analysed 1184 knees from 649 women for whom radiographic data were available at 
baseline (year 1) and year 5. The participants’ mean age (±standard deviation) was 54 (±6) 
years. Figure 1 shows the selection criteria for the included knees and that 109 knees (9.2%, 
95 women) had developed RKOA by year 5.  
 
We excluded 20 categorical variables for having less than 5 observations in at least 1 category. 
Following univariable analysis, we excluded 53 of the possible variables (see Supplementary 
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Tables S1-S6 for univariable analysis results). Missing data for the variables included in this 
study are shown in Supplementary Table S7.  
 
The remaining 30 potential predictors were used to develop the model, of which 24 are 
routinely available to clinicians and 6 are radiographic variables. Table 1 compare the 30 
candidate risk factors between knees that developed RKOA within 4 years (by year 5) and 
those that did not. Supplementary Table S8 describes the 30 potential risk factors in greater 
detail.  
 
Almost half of the 30 potential factors have been described previously (9, 11, 18-20). Sixteen 
were evaluated for the first time in the development of a model of RKOA incidence: age at 
menopause, waist-to-circumference ratio, weight at 20 years old, knee-level quadriceps 
circumference, painkiller use, duration of knee symptoms in months, stiffness during joint 
examination, pain during joint examination, swelling during joint examination, knees injured 
enough to rest them for a week, unstable knees (knees that give way), weather affecting knees, 
loss of height or a stoop or hump, number of thoracic and lumbar vertebrae with osteophytes 
or discs with narrowing space (26), and hip α-angle (the angle between the acetabular roof and 
ilium’s vertical cortex).  
 
Multivariable models predicting RKOA  
The 24 of the 30 candidate predictors that are routinely available to clinicians (excluding the 
radiographic variables) were used to build the clinical multivariable model. Three candidates 
were identified as predictors (P<0.157): older age, greater quadriceps circumference, and 
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higher urine concentration of C-terminal telopeptide of type II collagen (CTX-II) corrected for 
creatinine at baseline (Table 2).  
 
The model is described by: 
Predicted probability of incident RKOA at year 5 = 1/(1+exp(-(-10.54 + 0.06 x age + 0.11 x 
quadriceps circumference + 0.63 x CTX-II (≥229.9 ng/mL category))).  
 
All 30 candidate predictors, including the radiographic variables, were used to build the 
radiographic multivariable model. Seven candidate variables were identified as predictors 
(P<0.157): older age, greater quadriceps circumference, presence of knee pain, K/L grade 1, 
contralateral RKOA at baseline, greater hip α-angle (28), and greater bone mineral density 
(BMD) Z-score at the spine (Table 2).  
 
The model is described by: 
Predicted probability of incident RKOA at year 5 = 1/(1+exp(-11.64 + 0.07 x age + 0.09 x 
quadriceps circumference + 0.53 x knee pain (same side) + 1.88 x knee K/L grade 1 + 1.09 x 
contralateral knee with K/L grade≥2 + 0.02 x hip α-angle + 0.28 x BMD Z-score at the spine 
L1-L4)).  
 
Model performance 
The upper panels of Figure 2 show the models’ discrimination. The radiographic model (right 
upper panel) showed better discrimination (AUC = 0.809, optimism = 0.012, bias-corrected 
AUC = 0.797) than the more limited clinical model (left upper panel, AUC = 0.699, optimism 
= 0.007, bias-corrected AUC = 0.692).  
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The agreement between the predicted and observed values of incident RKOA at year 5 is shown 
in the lower panels of Figure 2 and was assessed visually. Both models showed good 
calibration: all of the 95% confidence interval (CI) bars and some of the mean values (data 
points) intersect with the 45° line that indicates perfect agreement between the predicted and 
observed RKOA at year 5. However, both models slightly overestimated some of the lowest 
values. Our models therefore estimated that fewer patients would develop RKOA than was 
observed in our sample for those patients that had a low probability of developing RKOA. 
 
Clinical scoring tool 
The clinical model with routinely available variables (age, quadriceps circumference, and 
urine CTX-II) was developed into a clinical scoring tool (Table 3). The tool gives scores 
from 0 (lowest risk) to 17 (greatest risk). A woman will reach the highest score if she is 52-66 
years old, has a quadriceps with a circumference of 44-63 cm, and has a concentration of 
urine CTX-II of 0.23-1.34 mcg/mL.  
 
We also generated a tool that adds the four radiographic variables to the three routinely 
available variables, for those physicians with access to radiographs (Supplementary Table 
S9). 
 
DISCUSSION 
We developed and internally validated two prediction models for incident RKOA in middle-
aged women, one using information readily available to clinicians (clinical model) and the 
other supplementing this information with radiographic features (radiographic model). Both 
models showed good predictive validity, with bias-corrected AUCs of 0.692 (clinical model) 
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and 0.797 (radiographic model). Calibration tests showed good agreement between the 
observed and predicted incident RKOA.  
 
We also developed a clinical risk score tool to identify women at short-term risk of RKOA, 
using the predictors identified in the clinical model so that it can easily be used in clinical 
practice. A participant with a score of 5 would have a 30% ((5/17) x 100 = 29.4) probability 
of developing RKOA within 4 years. Higher risk is driven by the urine CTX-II marker. 
Patients with no risk from age (44–48 years) or quadriceps circumference (32–39 cm) but 
with high urine CTX-II (0.2–1.3 µg/mL) would have a 77% ((13/17) x 100 = 76.5) 
probability of developing RKOA within 4 years. 
 
Older age, bigger quadriceps circumference, and elevated urine CTX-II were predictors of 
incident RKOA in the clinical model. When radiographic features, hip α-angle, and bone 
density were added to form the radiographic model, the predictive ability improved 
considerably, increasing from 69% to 80%. The radiographic model selected age and 
quadriceps circumference like the clinical model, but did not select urine CTX-II. The 
radiographic model also selected knee pain, baseline K/L grade, contralateral knee with 
RKOA at baseline, hip α-angle, and Z score BMD at the spine L1-L4. The principal 
predictors (those with the highest odds ratios and strongest predictive ability) in the 
radiographic model were RKOA in the contralateral knee (3 times more associated with 
incidence RKOA than a contralateral knee free of RKOA, Table 2) and K/L grade 1 in the 
index knee (6.5 times more related to incidence RKOA than the index knee with K/L grade 0, 
Table 2), at baseline.  
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Within the National Institute for Health and Care Excellence (NICE) recommendations (29), 
patients with no pain or symptoms of knee osteoarthritis who are 45 years old or older and 
have an activity associated with knee pain could be assessed using our clinical predictive tool 
to predict their risk of developing RKOA in the next 4 years. The radiographic predictive tool 
that includes radiographic variables could be useful in clinical practice if further investigation 
is undertaken when diagnosis is in doubt or in preparation for referral to a rheumatologist.  
 
Age (selected in both models) and knee pain (selected in the radiographic model) are both well-
known risk factors for the incidence of RKOA (4, 10, 30-32).  
 
Our models showed that a greater quadriceps circumference was associated with incidence 
RKOA. A larger circumference may reflect more subcutaneous fat around the knee. Individuals 
who are overweight may have added issues with load and muscle imbalance, which can lead 
to quadriceps inflammation (33, 34). It is easy to measure the quadriceps circumference in 
clinical practice, making this a useful predictor (35).  
  
As urine CTX-II is a by-product of the degradation of knee components such as matrix and 
cartilage, its presence has been associated with osteoarthritis and osteoporosis (36). A meta-
analysis that included the Chingford cohort used here found that a higher likelihood of 
incident knee osteoarthritis was associated with higher levels of urine CTX-II (37). Although 
urine CTX-II was a significant predictor in our clinical model, it was not selected in our 
radiographic model. Urine CTX-II may therefore be a surrogate for radiographic factors, 
which could be useful in clinical practice when X-rays are unavailable. 
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A K/L grade of 1 and contralateral RKOA were strong predictors of RKOA in our radiographic 
model. These associations are already well-known (7, 8) and an existing person-level 
prediction model also includes K/L grade of 1 as a predictor (7).  
 
This is the first time that hip α-angle has been identified as a predictor of incident RKOA. The 
α-angle is a radiological measure used to diagnose femoroacetabular impingement at the hip, 
which causes hip pain and dysfunction (38). The most common threshold for diagnosis is an 
angle greater than 50° (28). The mean of α-angles in the group with RKOA at year 5 exceeded 
this threshold in our study. A larger hip α-angle may thus reflect serious biomechanical changes 
and point to an osteoarthritis origin beyond the knee that leads to an increased risk of knee 
RKOA. For example, a greater hip α-angle might indicate abnormal rotation of the tibia with 
respect to the femur, leading to knee osteoarthritis (39). It may also be related to hip 
osteoarthritis. Hip osteoarthritis flexes, externally rotates, and adducts the hip. These changes 
may lead to apparent limb shortening.  
 
We found higher BMD at the spine in women with short-term incident RKOA than in those 
without RKOA. A lumbar spine with a higher BMD has previously been associated with knee 
osteoarthritis (40, 41). A recent population-based study found a correlation between the spine 
BMD and knee osteophyte score, and a negative correlation between the spine BMD and JSN 
(42). High systemic BMD has also been associated with incident RKOA (43, 44),  and an 
estimated 45% of the association between high bone mass and knee osteoarthritis may be 
mediated by BMI (45). However, this is the first time that higher spine BMD has been shown 
to be useful in a predictive model of RKOA. 
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Clinical practice needs predictive tools for identifying those at risk of developing RKOA in the 
short term (6, 46). Identifying those at short-term risk will allow new interventions targeting 
this population to be developed. However, two of the three previously developed models for 
incidence of RKOA followed people for 9 (7) and 12 (9) years. They therefore selected 
prognostic factors that could predict RKOA in the medium- to long-term. Riddle et al. 
investigated short-term risk by following participants for 5 years, but focused on older people 
with a higher BMI who were at high risk for developing osteoarthritis, and only considered 
those with radiographic tibiofemoral osteoarthritis (8). Our model bridges this gap by 
predicting the short-term incidence of all RKOA.  
 
Unlike our study, none of the three previous studies (7-9) included any form of internal 
validation to account for optimism in the predictive performance of the developed models (25, 
47). The AUC values presented in these published studies would have been lower if internal 
validation were used.  
 
Kerkhof et al. also produced a clinical model that excluded radiographic variables but included 
age, CTX-II, and BMI (7). This model had reasonable discriminatory power (AUC = 0.66). 
Our clinical model used knee-level quadriceps circumference instead of BMI and had better 
slightly discriminatory power (AUC = 0.69) than Kerkhof’s clinical model. Both clinical 
models included urine CTX-II. It added little to the predictive value of their model, whereas 
higher urine CTX-II levels doubled the probability of short-term RKOA in our clinical model 
(48). Our clinical model was also better at predicting incidence RKOA than alternative models 
assessed by Kerkhof et al. that considered ambulation, disability, and genetic risk factors. 
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Our clinical model performed similarly (AUC = 0.69) to the model of Zhang et al. (9) when 
developed on the Nottingham knee osteoarthritis retrospective cohort (AUC = 0.70). However, 
our clinical model is simpler to implement because it only considers three predictors (age, 
knee-level quadriceps circumference, and urine CTX-II), in comparison with their six-predictor 
model (age, sex, BMI, occupational risk, family history of osteoarthritis, and previous serious 
knee injury).  
 
None of the existing models used calibration plots to check agreement between predicted and 
observed probabilities (7-9). Instead, they used the Hosmer-Lemeshow test. The TRIPOD 
guideline discourages its use because it has limited statistical power when assessing poor 
calibration and tends to give a significant result if a large enough sample is used (25). We 
presented calibration plots showing that the CIs for most of our models’ predictions overlapped 
with the 45° line, showing agreement with the observed RKOA incidence. The probability of 
developing incident RKOA in the next 4 years in our general population of middle-aged women 
varied between 3 out of 100 women and 20 out of 100 women. As this model was developed 
using data from a healthy, urban population of white middle-aged women, it cannot be assumed 
that the model will make accurate predictions in other populations. We suggest testing and 
validation before use in, for example, hospital inpatient, rural, younger female, older female, 
and male populations. 
 
Strengths and limitations 
This study has several strengths. Our knee-level approach allows to identify risk factors whose 
effects are connected to which side of the body they are in, in relation to the knee that developed 
RKOA: quadriceps circumference, knee pain evaluated by the physician, specific knee K/L 
grade, contralateral knee with RKOA, and ipsilateral hip α-angle.   
Predicting incident RKOA in women 
 20 
 
The reproducibility of the model was ensured by using multiple imputation and bootstrapping 
(49), so that only significant predictors were selected. We grouped the risk factors together into 
those that clinicians readily have access to and those that require radiography. The resulting 
two risk models support clinical decision-making between the physician and patient in two 
common scenarios, before and after radiography. We created a risk prediction tool to assess 
the short-term risk of incident RKOA, which will help physicians to inform their patients about 
their risk for incident RKOA and support the physician in addressing preventive measures to 
avoid the outcome.  
 
The study also has potential limitations. As uncontrolled parameters such as lifestyle factors 
may have changed since this study started in 1988-1989, the results may not be generalisable 
to individuals in 2018. However, our findings are consistent with recent studies (4, 12, 13, 37), 
which support that these potential differences may not have any impact on the relationship 
between the selected predictors and RKOA.  
 
External validation was beyond the scope of this study, as an existing cohort of sufficient 
sample size containing the required predictors could not be found. Before the models are used 
in clinical practice, they should be externally validated using participant data from other than 
the Chingford study to test whether the model performance is overly optimistic. The models’ 
generalisability in men, mixed-gender, and non-white populations should also be tested. It is 
possible that the predictive capacity identified here only applies to individuals with existing 
radiographic changes, which could limit the clinical utility of the tool. This requires further 
investigation. 
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K/L grade≥2 does not account for knee symptoms. However, K/L ≥2 is strongly associated 
with knee pain and closely linked to knee replacement (32). We instead tested knee pain as a 
potential predictor, which was selected in the radiographic model. 
 
Conclusions 
We developed two predictive models for short-term incidence of RKOA in middle-aged, 
predominantly white women, a simple clinical model and a more complete radiographic model. 
The clinical model uses three variables that clinicians can easily measure and use to identify 
and inform women who have knees at higher risk of RKOA in the clinical setting: age, 
quadriceps circumference, and urine CTX-II level. The radiographic predictive model uses 
seven variables and includes radiographic factors such as hip α-angle to increase the predictive 
capacity of the clinical model of short-term incidence of RKOA.  
 
This is the first time that ipsilateral hip α-angle has been identified as a predictor of RKOA. 
The selection of hip α-angle, BMD at the lumbar spine, and contralateral knee osteoarthritis as 
predictors of RKOA suggest osteoarthritis origins beyond the knee area, although further 
research is needed before a mechanism for how these cause RKOA can be suggested. We also 
developed a risk score tool to help clinicians use the clinical model. Identifying women with 
knees at high risk of developing RKOA will enable preventive measures to be tested. Once 
externally validated, both models and the risk score tool could be useful in identifying 
participants for clinical trials.  
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TABLES 
Table 1. Baseline features of knees that do and do not develop radiographic knee 
osteoarthritis in 4 years.  
Patient features No RKOA (1075) RKOA (109) P-value 
Age, years 53 (48, 58) 56 (51, 60) <0.001a 
Age at menopause   0.024 
No menopause 278 (25.9) 21 (19.3)  
<48 years old 401 (37.3) 32 (29.4)  
49-51 years old 258 (24.0) 34 (31.2)  
>51 years old 138 (12.8) 22 (20.2)  
BMI (kg/m2) 24.2 (22.5, 27.0) 26.4 (23.7, 28.9) <0.001 
Waist-hip ratio 0.76 (0.73, 0.80) 0.78 (0.75, 0.81) 0.005 
Weight at 20 years old (kg) 54 (50, 60) 57 (53, 63) 0.002 
Quadriceps circumference (cm)* 42 (39, 45) 44 (41, 47) <0.001 
Medication    
Oral contraceptive pill 363 (33.8) 29 (26.6) 0.130 
Pain killers 79 (7.4) 13(11.9) 0.089 
Biomarkers    
CTX-II tertiles (corrected for 
creatinine) 
  <0.001 
52.7 ‒ 133.1 ng/mL 294 (34.5) 14 (18.9)  
133.2 ‒ 229.8 ng/mL 290 (34.0) 19 (25.7)  
≥229.9 ng/mL 268 (31.5) 41 (55.4)  
Oestradiol (E2) (picomol/L) 21 (20, 239) 20 (20, 153) 0.134b 
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Knee symptoms and height loss, 
stoop, or hump 
   
Duration (months)* 0 (0-1) 0 (0-12) 0.051c 
Presence of stiffness* 247 (23.0) 34 (31.2) 0.055 
Presence of pain* 238 (22.1) 37 (33.9) 0.005 
Presence of swelling* 93 (8.6) 14 (12.8) 0.146 
Injured knees for a week 81 (8.7) 19 (19.2) 0.001 
Pain while walking 177 (19.1) 27 (27.3) 0.051 
Pain while descending stairs 188 (20.2) 30 (30.3) 0.020 
Pain while bending 188 (20.4) 28 (28.9) 0.051 
Pain while sitting 112 (12.1) 19 (19.2) 0.043 
Unstable knees 165 (17.8) 32 (33.0) <0.001 
Morning stiffness 233 (25.1) 33 (33.3) 0.077 
Weather affects knees 157 (16.9) 28 (28.0) 0.006 
Job/daily activities involved knee 
bending 10 years agoǂ 
  0.020 
None/little/moderate 699 (71.8) 58 (60.4)  
A lot/always 275 (28.2) 38 (39.6)  
Loss of height, stoop, or hump 119 (11.1) 17 (15.6) 0.160 
Radiology factors    
Baseline knee K/L grade*   <0.001 
0 grade 1029 (95.7) 75 (68.8)  
1 grade 46 (4.3) 34 (31.2)  
Contralateral knee with RKOA at 
baseline* 
83 (7.7) 31 (28.4) <0.001 
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Hip α-angle (degrees)* 55.4 (±18.3) 61.8 (±22.7) 0.004d 
Spine – osteophytes (n)   0.080 
0-3 676 (66.3) 57 (57.6)  
>3 343 (33.7) 42 (42.4)  
Spine discs - narrowing space (n)   0.027 
0 900 (87.6) 79 (79.8)  
>3 127 (12.4) 20 (20.2)  
BMD Z-score at the spine L1-L4  0.32 (±1.25) 0.86 (±1.41) 0.002 
These factors were considered potential prognostic factors in both the clinical and 
radiographic models. The data were collected in London, 1989/91. * Side level. ǂ collected at 
year 3. a Significant F-statistic. b Analysis of variance. Variances between groups were not 
equal. c Significant F-statistics (0.53) when there were no symptoms on the knee (values=0) 
were excluded. d Analysis of variance. Bartlett’s test for equal variances (P = 0.006). Median 
and interquartile range (IQR) were used for continuous variables. Number and percentage 
(%) were used for categorical variables. Body mass index, BMI; crosslinked C-telopeptide of 
type II collagen, CTX-II; radiographic knee osteoarthritis (Kellgren/Lawrence grade≥2), 
RKOA. Bone mineral density, BMD. 
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Table 2. Multivariable logistic regression models identifying the predictors of RKOA in 
women after 4 years of follow-up.  
Intercept and predictors  
(reference category) 
Clinical model ─ % 
retained; OR (95% CI) 
Radiographic model ─ 
% retained; OR (95% 
CI) 
Intercept 2.64x10-5 8.79x10-6 
Age, years 91%; 1.06 (1.02, 1.10) 78%; 1.07 (1.02, 1.12) 
Quadriceps circumference, cm* 94%; 1.11 (1.06, 1.17) 91%; 1.09 (1.03, 1.15) 
CTX-II tertilesǂ, ng/mL (52.7‒
133.1) 
  
≥229.9 ng/mL 85%; 1.89 (1.13, 3.14) ─ 
Presence of pain* (No)   
Yes ─ 73%; 1.70 (0.99, 2.90) 
Baseline knee K/L grade* (grade 0)   
Grade 1 ─ 100%; 6.54 (3.62, 11.83) 
Contralateral knee with RKOA at 
baseline* (No) 
  
Yes ─ 95%; 2.97 (1.65, 5.33) 
Hip α-angle, degrees* ─ 95%; 1.02 (1.01, 1.03) 
Z score BMD at the spine L1-L4 ─ 93%; 1.32 (1.06, 1.64) 
AUC 0.699 0.809 
Optimism 0.7 1.2 
Bias-corrected AUC 0.692 0.797 
“Retained” indicates how often, as a percentage, a variable was retained in the final model 
after 200 bootstrapping attempts. * Side level. ǂ133.2 ‒ 229.8 ng/mL of urine CTX-II was 
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retained only 3% of the time and was not considered for prediction. Body mass index, BMI; 
crosslinked C-telopeptide of type II collagen, CTX-II; odds ratio, OR; confidence interval, 
CI; Kellgren/Lawrence, K/L; radiographic knee osteoarthritis (K/L grade≥2), RKOA; bone 
mineral density, BMD; area under the receiver characteristic curve, AUC. 
  
Predicting incident RKOA in women 
 34 
Table 3. Risk score points system for identifying women at risk of developing RKOA in the 
next 4 years, created using predictor variables identified in the clinical model.  
Baseline risk factor Regression 
coefficient 
Reference 
value 
Risk 
score 
Final risk 
score 
Age, years 1.06    
44 to 48  46 4 0 
49 to 51  50 5 1 
52 to 66  59 6 2 
Quadriceps circumference, cm* 1.11    
32 to 39  35.5 3 0 
40 to 43  41.5 4 1 
44 to 63  53.5 5 2 
CTX-II tertiles (mcg/mL)ǂ 1.9    
0.0527 to 0.1331  0.09 1 0 
0.1332 to 0.2298  0.18 3 2 
0.2299 to 1.3381  0.78 14 13 
Score of 0 indicates lowest risk and score of 17 indicates greatest risk (column “final risk 
score”). To work out your patient’s risk 1. Find their measurement for each characteristic. 2. 
Circle the appropriate final risk score for each characteristic. 3. Add up the scores to give a 
total risk score. 4. Convert the risk score to a % probability by dividing the score by the 
maximum possible (17) and multiplying by 100. * Side level. ǂ Original values in 
nanograms/mL transformed to micrograms/mL, i.e. divided by 1000. CTX-II, crosslinked C-
telopeptide of type II collagen; Radiographic knee osteoarthritis (K/L grade≥2), RKOA.   
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FIGURE LEGENDS 
Figure 1. Flowchart showing selection criteria and numbers excluded at each stage of knees 
from women who developed knee osteoarthritis within 4 years. 
Figure 2. Discrimination and calibration plots with bias-corrected AUC.  
The upper panels show discrimination when using age, quadriceps circumference, and CTX-
II as predictors of incident RKOA (clinical model; left panel), and when using age, 
quadriceps, painful knee, and radiologic factors as predictors (radiographic model; right 
panel). The area under the solid line and above the dotted line (line of no-discrimination) 
indicates the ability of the model to predict whether patients will develop RKOA within 4 
years. The lower panels show the calibration of the imputed development dataset for the 
clinical (left) and radiographic model (right) models. The sample used for validation was 
divided into ten equal parts, according to their predicted risk. For each decile, the mean 
predicted risk is shown on the x-axis and the mean observed cases on the y-axis. The bars 
indicate 95% Agresti–Coull confidence intervals. The red straight line indicates perfect 
agreement between the observed and predicted values.  
Area under the receiver characteristic curve, AUC; urine crosslinked C-telopeptide of type II 
collagen, CTX-II; radiographic knee osteoarthritis (Kellgren/Lawrence grade≥2), RKOA. 
